Trastuzumab emtansine (solution)
Selected Variant
HY-P9921A-01
Size: 1 mg
Trastuzumab emtansine (Ado-Trastuzumab emtansine) is an antibody-drug conjugate (ADC) that incorporates the HER2-targeted antitumor properties of trastuzumab with the cytotoxic activity of the microtubule-inhibitory agent DM1 (derivative of maytansine), and the drug-linker conjugate for ADC is SMCC-DM1. Trastuzumab emtansine can be used for the research of advanced breast cancer[1][2].
Product Specifications
CAS Number
1018448-65-1
Product Name Alternative
Ado-Trastuzumab emtansine (solution) ; PRO132365 (solution) ; T-DM 1 (solution)
UNSPSC
12352203
Target
Antibody-Drug Conjugates (ADCs) ; EGFR
Type
ADC Related
Related Pathways
Antibody-drug Conjugate/ADC Related; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/trastuzumab-emtansine-solution.html
Purity
98.27
Solubility
10 mM in DMSO
Smiles
[Trastuzumabemtansine(solution)]
Molecular Weight
149114 (average)
References & Citations
Shipping Conditions
Dry Ice
Storage Conditions
-80°C, protect from light
Scientific Category
ADC Related
Clinical Information
Launched
Available Sizes
Price
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog